SEMA4D binds three types of receptors, Plexin-B1 (PLXNB1), Plexin-B2 (PLXNB2), and CD72, which are all expressed by APCs, endothelial cells, and tumor cells [368]. Here, PLXNB2 is linked to neoplasm.